(Q38781182)

6 September 2017

0 references

Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 September 2017

1 reference

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Veeravich Jaruvongvanich

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Anawin Sanguankeo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

18 March 2016

1 reference

Digestive Diseases and Sciences

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2389-2396

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

Cholesterol gallstone disease.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

The burden of selected digestive diseases in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

The burden of gastrointestinal and liver diseases, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Nonalcoholic fatty liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

The metabolic syndrome is associated with complicated gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Insulin and gall stones: a population case control study in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Association of diabetes, serum insulin, and C-peptide with gallbladder disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Gallbladder disease is associated with insulin resistance in a high risk Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Cholecystectomy does not significantly increase the risk of fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Prevalence of and risk factors for gallstones in Uighur and Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Metabolic syndrome and gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Insulin resistance causes human gallbladder dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Macronutrients and insulin resistance in cholesterol gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Epidemiology of gallbladder disease: cholelithiasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Gallstones: environment, lifestyle and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4125-2

Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors

21 January 2018

1 reference

12 December 2020

Long-term effects of cholecystectomy on bile acid metabolism.

1 reference

12 December 2020

Prospective study of abdominal adiposity and gallstone disease in US men

1 reference

12 December 2020

Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey

1 reference

12 December 2020

Cholesterol gallstones: a fellow traveler with metabolic syndrome?

1 reference

12 December 2020

10.1007/S10620-016-4125-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 June 2020

1039094193

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993825%20AND%20SRC:MED&resulttype=core&format=json